Replies to post #703576 on NorthWest Biotherapeutics Inc (NWBO)

[drugrunner]

IC — —MHRA is the golden ticket to ROW approval

Thinking anything less just proves you are a BASHER and your sole purpose here is FUD

[kabunushi]

You don't know anything. There are some 4500 new gbm patients annually in the UK. As DcVax quickly becomes SOC for GBM in the UK under the very enthusiastic leadership of the UK's most renown GBM clinician and researcher Dr. K. Ashkan of King's College, London, 50% penetration of that market at only $20,000 gross profit (I imagine the margin will be several times that but the pricing is still unknown to us) is enough to bring NW's whole company to cash flow break even. Go ahead, keep opening your mouth and proving how clueless you are.